Brainsway Says High Frequency TMS Treatment Improved Alzheimer’s

Brainsway Ltd. (BRIN) said interim results of a clinical test showed high frequency treatment with its device for patients suffering from Alzheimer’s improved their condition. The company’s head researcher has recommended halting tests using low frequency treatment following the results of the test that was carried out in Israel, the company said in a statement to the Tel Aviv Stock Exchange today.

To contact the reporter on this story: Gwen Ackerman in Jerusalem at

To contact the editor responsible for this story: Gwen Ackerman at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.